Angiogenesis and angiogenic mediators in haematological malignancies

被引：92

作者：

Mangi, MH ^{[1
]}

Newland, AC ^{[1
]}

机构：

[1] Royal London Hosp, Dept Haematol, London E1 1BB, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2000年 / 111卷 / 01期

关键词：

angiogenesis; vascular endothelial growth factors (VEGF); leukaemia; lymphoma; myeloma;

D O I：

10.1046/j.1365-2141.2000.02104.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：43 / 51

页数：9

共 66 条

[1]

Aguayo A, 1998, BLOOD, V92, p607A

[2] Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia [J].

Aguayo, A ;

Estey, E ;

Kantarjian, H ;

Mansouri, T ;

Gidel, C ;

Keating, M ;

Giles, F ;

Estrov, Z ;

Barlogie, B ;

Albitar, M .

BLOOD, 1999, 94 (11) :3717-3721

[3] Isolation of putative progenitor endothelial cells for angiogenesis [J].

Asahara, T ;

Murohara, T ;

Sullivan, A ;

Silver, M ;

vanderZee, R ;

Li, T ;

Witzenbichler, B ;

Schatteman, G ;

Isner, JM .

SCIENCE, 1997, 275 (5302) :964-967

[4]

Banks RE, 1999, BRIT J CANCER, V79, P372

[5] Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].

Benjamin, LE ;

Golijanin, D ;

Itin, A ;

Pode, D ;

Keshet, E .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165

[6] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].

Boehm, T ;

Folkman, J ;

Browder, T ;

OReilly, MS .

NATURE, 1997, 390 (6658) :404-407

[7]

Branemark PI., 1968, ADV MICROCIRC, P1

[8]

BRAWER MK, 1994, CANCER, V73, P678, DOI 10.1002/1097-0142(19940201)73:3<678::AID-CNCR2820730329>3.0.CO

[9]

2-6

[10] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].

BROOKS, PC ;

CLARK, RAF ;

CHERESH, DA .

SCIENCE, 1994, 264 (5158) :569-571

← 1 2 3 4 5 6 7 →